Chronic kidney disease disrupts the body’s mineral control system, causing more than 50% of patients with moderate to severe disease to develop bone and heart problems. According to Gram Research analysis, this happens because kidneys can’t regulate phosphate, vitamin D, and parathyroid hormone properly, leading to weak bones, increased fracture risk, and calcium deposits in blood vessels. Early detection through blood tests and bone density screening, combined with medications and dietary changes, can prevent serious complications.
When kidneys don’t work properly, they can’t control minerals in your body, leading to serious problems with bones and heart health. According to Gram Research analysis, more than half of people with moderate to severe kidney disease develop a condition called CKD-MBD that weakens bones and increases heart disease risk. This review examines how kidney disease disrupts the body’s mineral balance, what happens to bones and blood vessels, and what treatments doctors can use to prevent fractures and heart problems. Understanding these connections helps patients and doctors catch and treat these complications early.
Key Statistics
A comprehensive review of research through December 2025 found that chronic kidney disease-mineral bone disorder affects more than 50% of patients with moderate to severe kidney disease, significantly increasing their risk for fractures and cardiovascular events.
According to the Journal of Endocrinological Investigation review, mixed uremic osteodystrophy—a combination of both high and low bone turnover—is more common than pure forms of bone disease in kidney disease patients.
Research shows that adynamic bone disease, where bones become weak and brittle, is particularly prevalent in early-stage chronic kidney disease, peritoneal dialysis patients, and those who have received kidney transplants.
The review identified that fibroblast-growth factor 23 (FGF-23) elevation and bone resistance to parathyroid hormone are among the earliest detectable abnormalities in kidney disease-mineral bone disorder, appearing before other mineral imbalances develop.
The Quick Take
- What they studied: How chronic kidney disease causes problems with minerals, bones, and the heart, and what treatments work best
- Who participated: This is a review article that analyzed research published up to December 2025 about kidney disease and bone-mineral disorders
- Key finding: More than 50% of people with moderate to severe kidney disease develop mineral and bone problems that increase fracture risk and heart disease
- What it means for you: If you have kidney disease, getting your minerals checked regularly and treating imbalances early can help prevent broken bones and heart problems. Talk to your doctor about screening and treatment options.
The Research Details
This is a review article, not a new study with patients. The researchers searched medical databases for all published research about kidney disease and mineral-bone disorders through December 2025. They looked at how the condition develops, what symptoms appear, and what treatments doctors use. By reviewing hundreds of existing studies, they created a comprehensive guide to understanding this complex problem.
The researchers organized their findings by looking at what happens first in the disease process, then what complications develop over time. They examined different types of kidney disease patients—those with early kidney disease, those on dialysis, and those who received kidney transplants—because the condition affects each group differently.
This approach is valuable because it brings together knowledge from many different studies to give doctors and patients a complete picture of the problem and the best treatment options available.
Understanding how kidney disease damages bones and hearts is critical because these complications are common and serious. By reviewing all available research, doctors can learn which patients need screening, how to catch problems early, and which treatments work best. This helps prevent fractures and heart attacks in vulnerable patients.
This is a comprehensive review published in a respected medical journal. The authors searched databases systematically and included research through late 2025, making it current. However, as a review article rather than a new study, it summarizes existing research rather than providing new data. The strength comes from bringing together many studies to identify patterns and best practices.
What the Results Show
The research shows that kidney disease disrupts the body’s mineral control system in a specific sequence. First, the body accumulates too much phosphate and produces excess FGF-23 (a hormone that regulates minerals). The bones become resistant to parathyroid hormone (PTH), which normally keeps calcium and phosphate balanced. Next, the body can’t make enough active vitamin D, leading to secondary hyperparathyroidism—when the parathyroid glands work overtime trying to fix the mineral imbalance.
These mineral imbalances cause two main bone problems: either bones break down too quickly (high bone turnover) or they become weak and brittle (adynamic bone disease). Mixed uremic osteodystrophy, a combination of both problems, is actually more common than pure forms of either condition.
The mineral imbalances also damage the heart and blood vessels. Calcium deposits build up in artery walls, the heart muscle thickens, and FGF-23 directly harms heart function. These changes increase the risk of heart attacks and strokes in kidney disease patients.
The review found that different kidney disease patients have different bone problems. People in early kidney disease stages and those on peritoneal dialysis (a type of home dialysis) more commonly develop adynamic bone disease. Osteomalacia (soft bones from vitamin D deficiency) is actually rare in modern kidney disease treatment. After kidney transplantation, bone problems can persist or develop differently than expected.
This review confirms and updates previous understanding of how kidney disease affects bones and hearts. It shows that the mineral control system breaks down in a predictable sequence, which helps doctors know what to look for and when. The finding that adynamic bone disease is more common than previously thought in certain patient groups represents an important shift in how doctors approach treatment.
This is a review of existing research, not a new study, so it depends on the quality of previously published work. The review doesn’t provide new patient data or compare treatments in a controlled way. Some treatments mentioned (like newer bone medications) have limited research in kidney disease patients, mostly studied in post-menopausal women without kidney disease. The authors note that better bone turnover markers specific to kidney disease are needed to improve fracture prevention.
The Bottom Line
For people with kidney disease: Get regular blood tests to check mineral levels (calcium, phosphate, vitamin D, and PTH). Work with your kidney doctor to control phosphate intake through diet and medications if needed. Take vitamin D supplements as prescribed. For severe cases, medications like calcimimetics or vitamin D analogues can help control PTH levels. Bone density testing helps identify fracture risk. These recommendations have strong evidence, especially for preventing serious complications.
Anyone with moderate to severe chronic kidney disease should pay attention to these findings. People on dialysis or those who’ve had kidney transplants especially need monitoring. Those with a family history of kidney disease or early signs of kidney problems should discuss screening with their doctor. However, this research is most relevant to adults; children with kidney disease may need different approaches.
Mineral imbalances develop gradually over months to years as kidney function declines. Bone damage can take years to become severe enough to cause fractures. Starting treatment early—when kidney disease is first diagnosed—helps prevent these complications. Benefits from treatment appear over weeks to months for blood mineral levels, but bone strengthening takes 6-12 months or longer to show clear improvement.
Frequently Asked Questions
What is CKD-MBD and why does kidney disease cause it?
CKD-MBD is a condition where kidney disease disrupts mineral balance, affecting bones and the heart. Healthy kidneys control phosphate, calcium, and vitamin D levels. When kidneys fail, these minerals build up or become deficient, causing bones to weaken and calcium to deposit in blood vessels.
How can I tell if kidney disease is affecting my bones?
Early signs include bone pain, muscle weakness, or fractures from minor falls. Blood tests showing abnormal calcium, phosphate, vitamin D, or PTH levels are the first indicators. Bone density scans can detect weakening before symptoms appear. Ask your kidney doctor about screening if you have kidney disease.
What treatments prevent fractures in kidney disease patients?
Treatments include controlling phosphate through diet and medications, taking vitamin D supplements, and using drugs like calcimimetics or vitamin D analogues to lower PTH. For severe cases, parathyroid surgery may help. Bone-strengthening medications like denosumab and romosozumab show promise in dialysis patients.
Does kidney disease damage the heart the same way it damages bones?
No, but both happen from mineral imbalances. In the heart, excess minerals cause calcium deposits in arteries and thickening of heart muscle, increasing heart attack and stroke risk. Controlling minerals helps protect both bones and the heart.
How often should I get tested if I have kidney disease?
Most kidney disease patients need blood tests checking minerals every 3-6 months, depending on disease severity. Bone density screening is recommended at diagnosis and periodically afterward. Your kidney doctor will determine the right schedule based on your specific condition and test results.
Want to Apply This Research?
- Log your monthly blood test results for phosphate, calcium, vitamin D, and PTH levels. Track the trend over time to see if your mineral balance is improving or worsening. This helps you and your doctor adjust medications and diet as needed.
- Set reminders to take vitamin D and phosphate-binding medications with meals. Log your dietary phosphate intake by tracking foods high in phosphate (dairy, nuts, processed foods). Record any bone pain or fractures to discuss with your doctor.
- Create a quarterly review where you compare your mineral levels to previous months. Set goals for staying within target ranges your doctor recommends. Track medication adherence and note any side effects. Share this data with your kidney doctor at each visit to guide treatment adjustments.
This article reviews research about how kidney disease affects bones and heart health. It is not medical advice. If you have kidney disease or concerns about bone or heart health, consult your nephrologist (kidney doctor) or cardiologist. Treatment decisions should be made with your healthcare team based on your individual condition, blood test results, and medical history. Do not start, stop, or change medications without medical supervision.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.